Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy

Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients

(2016) Radu M Nanau et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Cancer and Immunomodulators in Inflammatory Bowel Diseases

(2015) Livia Biancone et al.   INFLAMMATORY BOWEL DISEASES

Use of Anti-Tumor Necrosis Factor Alpha Therapy in Patients with Concurrent Rheumatoid Arthritis and Hepatitis B or Hepatitis C: A Retrospective Analysis of 32 Patients

(2014) Eleonora Ballanti et al.   DRUG DEVELOPMENT RESEARCH

Management of Patients with Psoriasis Treated with Biological Drugs Needing a Surgical Treatment

(2014) Antonella Fabiano et al.   DRUG DEVELOPMENT RESEARCH

Emergence of Antinuclear Antibodies in Psoriatic Patients Treated with Infliximab: Personal Experience and Literature Review

(2014) Maria Sole Chimenti et al.   DRUG DEVELOPMENT RESEARCH

Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists

(2014) Valentina Germano et al.   Journal of Translational Medicine

Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients

(2014) Yukitomo Urata et al.   Modern Rheumatology

Adverse events in IBD: to stop or continue immune suppressant and biologic treatment

(2014) Leon P McLean et al.   Expert Review of Gastroenterology & Hepatology

Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease

(2013) N. Narula et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients

(2013) Ali Syed et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

(2013) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

(2013) John W Baddley et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09

(2013) A.B. Kimball et al.   BRITISH JOURNAL OF DERMATOLOGY

Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population-based Cohort Study With 30 Years of Follow-up Evaluation

(2013) Michael D. Kappelman et al.   Clinical Gastroenterology and Hepatology

Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor-  Inhibitors: Systematic Review of the Literature

(2013) S. S. Toussi et al.   CLINICAL INFECTIOUS DISEASES

Adverse Events of Tumor Necrosis Factor Inhibitors

(2013) Klaus Fellermann   DIGESTIVE DISEASES

Risk of Extraintestinal Solid Cancer with Anti-TNF Therapy in Adults with Inflammatory Bowel Disease

(2013) David Hudesman et al.   INFLAMMATORY BOWEL DISEASES

Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster

(2013) Kevin L. Winthrop et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis

(2013) Helene Che et al.   JOINT BONE SPINE

Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)

(2013) Fernando Magro et al.   Journal of Crohns & Colitis

Mycobacterial Infections in Patients Treated with Tumor Necrosis Factor Antagonists in South Korea

(2013) Sang Kook Lee et al.   LUNG

Cancer risk in immune-mediated inflammatory diseases (IMID)

(2013) Rudi Beyaert et al.   Molecular Cancer

Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis

(2013) Stephen S. Johnston et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery

(2012) Z. Yang et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register

(2012) James B Galloway et al.   ANNALS OF THE RHEUMATIC DISEASES

Mycobacterial diseases and antitumour necrosis factor therapy in USA

(2012) KL Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease

(2012) Millie D. Long et al.   GASTROENTEROLOGY

Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis

(2012) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening

(2012) Aranzazu Jauregui-Amezaga et al.   Journal of Crohns & Colitis

Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy

(2012) Elizabeth A. Brezinski et al.   PLoS One

Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses

(2012) Guillaume Moulis et al.   PLoS One

Infections and Biologic Therapy in Rheumatoid Arthritis

(2012) Kevin L. Winthrop   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Anti-TNF Treatment in Rheumatoid Arthritis

(2011) Janina Geiler et al.   CURRENT PHARMACEUTICAL DESIGN

Update upon efficacy and safety of TNF-α inhibitors

(2011) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?

(2011) Laurent Beaugerie   GUT

Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases

(2011) Carlos G. Grijalva et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Does Anti-Tumor Necrosis Factor-  Therapy Affect Risk of Serious Infection and Cancer in Patients with Rheumatoid Arthritis?: A Review of Longterm Data

(2011) E. C. KEYSTONE   JOURNAL OF RHEUMATOLOGY

Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

(2011) Y. KOMANO et al.   JOURNAL OF RHEUMATOLOGY

The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials

(2011) Erica D. Dommasch et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy

(2011) Roberto Pérez-Alvarez et al.   MEDICINE

TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis

(2011) Michael A. Lane et al.   MEDICINE

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

(2010) D. Vassilopoulos et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy

(2010) K. L. Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

(2010) D. Salmon-Ceron et al.   ANNALS OF THE RHEUMATIC DISEASES

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

(2010) I. Solovic et al.   EUROPEAN RESPIRATORY JOURNAL

Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls

(2010) Léia CR Silva et al.   Immunotherapy

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

(2010) Johan Askling et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries

(2010) X. Mariette et al.   RHEUMATOLOGY

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

(2010) A. A. Saad et al.   RHEUMATOLOGY

Safety and Efficacy of the Tumor Necrosis Factor Antagonists

(2010) F. Bachmann et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease

(2009) Josh Marehbian et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials

(2009) A. Fouque-Aubert et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

(2009) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry

(2009) F. Tubach et al.   ARTHRITIS AND RHEUMATISM

Initiation of rheumatoid arthritis treatments and the risk of serious infections

(2009) Carlos G. Grijalva et al.   RHEUMATOLOGY

The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events

(2008) J P Leombruno et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis

(2008) Allison L Smitten et al.   ARTHRITIS RESEARCH & THERAPY